{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:19:48Z","timestamp":1793132388399,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T00:00:00Z","timestamp":1459814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"American Recovery and Reinvestment Act Fund"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R15HL103431"],"award-info":[{"award-number":["1R15HL103431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5 R01 HL114677-02"],"award-info":[{"award-number":["5 R01 HL114677-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s11095-016-1911-7","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T20:10:42Z","timestamp":1459887042000},"page":"1696-1710","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH"],"prefix":"10.1007","volume":"33","author":[{"given":"Kamrun","family":"Nahar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jahidur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahriar","family":"Absar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad I.","family":"Al-Saikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrul","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"issue":"2","key":"1911_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4037\/ajcc1998.7.2.131","volume":"7","author":"J McHugh","year":"1998","unstructured":"McHugh J, Cheek DJ. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations. Am J Crit Care. 1998;7(2):131\u201340.","journal-title":"Am J Crit Care"},{"issue":"12 Suppl S","key":"1911_CR2","doi-asserted-by":"publisher","first-page":"68S","DOI":"10.1016\/j.jacc.2004.02.031","volume":"43","author":"HA Ghofrani","year":"2004","unstructured":"Ghofrani HA, Pepke-Zaba J, Barbera JA, Channick R, Keogh AM, Gomez-Sanchez MA, et al. Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):68S\u201372S.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"1911_CR3","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/nrcardio.2011.104","volume":"8","author":"DS O\u2019Callaghan","year":"2011","unstructured":"O\u2019Callaghan DS, Savale L, Montani D, Jais X, Sitbon O, Simonneau G, et al. Treatment of pulmonary arterial hypertension with targeted therapies. Nat Rev Cardiol. 2011;8(9):526\u201338.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"1911_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/2045-8932.97589","volume":"2","author":"RJ Barst","year":"2012","unstructured":"Barst RJ, Channick R, Ivy D, Goldstein B. Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulm Circ. 2012;2(2):139\u201347.","journal-title":"Pulm Circ"},{"issue":"3","key":"1911_CR5","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1164\/ajrccm.158.3.9708014","volume":"158","author":"B Weinberger","year":"1998","unstructured":"Weinberger B, Fakhrzadeh L, Heck DE, Laskin JD, Gardner CR, Laskin DL. Inhaled nitric oxide primes lung macrophages to produce reactive oxygen and nitrogen intermediates. Am J Respir Crit Care Med. 1998;158(3):931\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1911_CR6","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1093\/bja\/39.5.388","volume":"39","author":"J Clutton-Brock","year":"1967","unstructured":"Clutton-Brock J. Two cases of poisoning by contamination of nitrous oxide with higher oxides of nitrogen during anaesthesia. Br J Anaesth. 1967;39(5):388\u201392.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1911_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1586\/ers.11.5","volume":"5","author":"G Hagan","year":"2011","unstructured":"Hagan G, Pepke-Zaba J. Pulmonary hypertension, nitric oxide and nitric oxide-releasing compounds. Expert Rev Respir Med. 2011;5(2):163\u201371.","journal-title":"Expert Rev Respir Med"},{"issue":"8966","key":"1911_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(95)92681-X","volume":"346","author":"OI Miller","year":"1995","unstructured":"Miller OI, Tang SF, Keech A, Celermajer DS. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet. 1995;346(8966):51\u20132.","journal-title":"Lancet"},{"issue":"1","key":"1911_CR9","first-page":"4","volume":"4","author":"A Bernasconi","year":"2002","unstructured":"Bernasconi A, Beghetti M. Inhaled nitric oxide applications in paediatric practice. Imag Paediatr Cardiol. 2002;4(1):4\u201329.","journal-title":"Imag Paediatr Cardiol"},{"issue":"6","key":"1911_CR10","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/00003246-199406000-00009","volume":"22","author":"DL Wessel","year":"1994","unstructured":"Wessel DL, Adatia I, Thompson JE, Hickey PR. Delivery and monitoring of inhaled nitric-oxide in patients with pulmonary-hypertension. Crit Care Med. 1994;22(6):930\u20138.","journal-title":"Crit Care Med"},{"issue":"2","key":"1911_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/thorax.55.2.109","volume":"55","author":"K Ashutosh","year":"2000","unstructured":"Ashutosh K, Phadke K, Jackson JF, Steele D. Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thorax. 2000;55(2):109\u201313.","journal-title":"Thorax"},{"key":"1911_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0076-6879(96)68030-6","volume":"268","author":"LK Keefer","year":"1996","unstructured":"Keefer LK, Nims RW, Davies KM, Wink DA. \u201cNONOates\u201d (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol. 1996;268:281\u201393.","journal-title":"Methods Enzymol"},{"issue":"1","key":"1911_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0041-008X(03)00193-5","volume":"190","author":"CF Lam","year":"2003","unstructured":"Lam CF, Caterina P, Filion P, Ilett KF, van Heerden PV. The safety of aerosolized diethylenetriamine nitric oxide adduct after single-dose administration to anesthetized piglets and multiple-dose administration to conscious rats. Toxicol Appl Pharmacol. 2003;190(1):65\u201371.","journal-title":"Toxicol Appl Pharmacol"},{"issue":"4","key":"1911_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/00005344-199504000-00023","volume":"25","author":"DL Mooradian","year":"1995","unstructured":"Mooradian DL, Hutsell TC, Keefer LK. Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro. J Cardiovasc Pharmacol. 1995;25(4):674\u20138.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"3","key":"1911_CR15","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1378\/chest.123.3.869","volume":"123","author":"CF Lam","year":"2003","unstructured":"Lam CF, van Heerden PV, Ilett KF, Caterina P, Filion P. Two aerosolized nitric oxide adducts as selective pulmonary vasodilators for acute pulmonary hypertension. Chest. 2003;123(3):869\u201374.","journal-title":"Chest"},{"issue":"1","key":"1911_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12975-014-0376-4","volume":"6","author":"MA Kandadai","year":"2015","unstructured":"Kandadai MA, Meunier JM, Hart K, Holland CK, Shaw GJ. Plasmin-loaded echogenic liposomes for ultrasound-mediated thrombolysis. Transl Stroke Res. 2015;6(1):78\u201387.","journal-title":"Transl Stroke Res"},{"issue":"3","key":"1911_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/CAD.0000000000000182","volume":"26","author":"E Tahover","year":"2015","unstructured":"Tahover E, Patil YP, Gabizon AA. Emerging delivery systems to reduce doxorubicin cardiotoxicity and improve therapeutic index: focus on liposomes. Anti-Cancer Drugs. 2015;26(3):241\u201358.","journal-title":"Anti-Cancer Drugs"},{"issue":"1","key":"1911_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.virusres.2012.07.024","volume":"169","author":"YJ Yang","year":"2012","unstructured":"Yang YJ, Zhao PS, Zhang T, Wang HL, Liang HR, Zhao LL, et al. Small interfering RNAs targeting the rabies virus nucleoprotein gene. Virus Res. 2012;169(1):169\u201374.","journal-title":"Virus Res"},{"issue":"1","key":"1911_CR19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nano.2014.09.003","volume":"11","author":"H Koide","year":"2015","unstructured":"Koide H, Asai T, Kato H, Yonenaga N, Yokota M, Ando H, et al. Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin. Nanomedicine. 2015;11(1):185\u201394.","journal-title":"Nanomedicine"},{"key":"1911_CR20","first-page":"4979","volume":"9","author":"M Magalhaes","year":"2014","unstructured":"Magalhaes M, Farinha D, de Lima MC P, Faneca H. Increased gene delivery efficiency and specificity of a lipid-based nanosystem incorporating a glycolipid. Int J Nanomedicine. 2014;9:4979\u201389.","journal-title":"Int J Nanomedicine"},{"issue":"9","key":"1911_CR21","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/1389201015666141020154352","volume":"15","author":"W Weecharangsan","year":"2014","unstructured":"Weecharangsan W, Opanasopit P, Yingyongnarongkul BE, Kewsuwan P, Lee RJ. Co-delivery of plasmid DNA and antisense oligodeoxyribonucleotide into human carcinoma cells by cationic liposomes. Curr Pharm Biotechnol. 2014;15(9):790\u20139.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"1911_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1208\/s12248-014-9686-4","volume":"17","author":"EM Varypataki","year":"2015","unstructured":"Varypataki EM, van der Maaden K, Bouwstra J, Ossendorp F, Jiskoot W. Cationic liposomes loaded with a synthetic long peptide and poly(I:C): a defined adjuvanted vaccine for induction of antigen-specific T cell cytotoxicity. AAPS J. 2015;17(1):216\u201326.","journal-title":"AAPS J"},{"issue":"1","key":"1911_CR23","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","volume":"65","author":"TM Allen","year":"2013","unstructured":"Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36\u201348.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"1911_CR24","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1021\/mp500186a","volume":"11","author":"R Nahire","year":"2014","unstructured":"Nahire R, Hossain R, Patel R, Paul S, Meghnani V, Ambre AH, et al. pH-triggered echogenicity and contents release from liposomes. Mol Pharm. 2014;11(11):4059\u201368.","journal-title":"Mol Pharm"},{"issue":"1\u20132","key":"1911_CR25","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ijpharm.2014.01.007","volume":"464","author":"K Nahar","year":"2014","unstructured":"Nahar K, Absar S, Patel B, Ahsan F. Starch-coated magnetic liposomes as an inhalable carrier for accumulation of fasudil in the pulmonary vasculature. Int J Pharm. 2014;464(1\u20132):185\u201395.","journal-title":"Int J Pharm"},{"issue":"12","key":"1911_CR26","doi-asserted-by":"publisher","first-page":"4374","DOI":"10.1021\/mp500456k","volume":"11","author":"K Nahar","year":"2014","unstructured":"Nahar K, Absar S, Gupta N, Kotamraju VR, McMurtry IF, Oka M, et al. Peptide-coated liposomal fasudil enhances site specific vasodilation in pulmonary arterial hypertension. Mol Pharm. 2014;11(12):4374\u201384.","journal-title":"Mol Pharm"},{"issue":"9","key":"1911_CR27","doi-asserted-by":"publisher","first-page":"800","DOI":"10.2174\/138920101509141107122927","volume":"15","author":"Z Guo","year":"2014","unstructured":"Guo Z, Li Y, Fu Y, Guo T, Li X, Yang S, et al. Enhanced antisense oligonucleotide delivery using cationic liposomes incorporating Fatty Acid-modified polyethylenimine. Curr Pharm Biotechnol. 2014;15(9):800\u20135.","journal-title":"Curr Pharm Biotechnol"},{"issue":"7","key":"1911_CR28","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1021\/bc5004313","volume":"26","author":"W Alshaer","year":"2015","unstructured":"Alshaer W, Hillaireau H, Vergnaud J, Ismail S, Fattal E. Functionalizing liposomes with anti-CD44 aptamer for selective targeting of cancer cells. Bioconjugate Chem. 2015;26(7):1307\u201313.","journal-title":"Bioconjugate Chem"},{"issue":"2","key":"1911_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1089\/ars.2007.1906","volume":"10","author":"CR Kliment","year":"2008","unstructured":"Kliment CR, Tobolewski JM, Manni ML, Tan RJ, Enghild J, Oury TD. Extracellular superoxide dismutase protects against matrix degradation of heparan sulfate in the lung. Antioxid Redox Signal. 2008;10(2):261\u20138.","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"1911_CR30","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1016\/j.ajpath.2011.02.032","volume":"178","author":"T Urakami","year":"2011","unstructured":"Urakami T, Jarvinen TA, Toba M, Sawada J, Ambalavanan N, Mann D, et al. Peptide-directed highly selective targeting of pulmonary arterial hypertension. Am J Pathol. 2011;178(6):2489\u201395.","journal-title":"Am J Pathol"},{"issue":"6","key":"1911_CR31","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1007\/s11095-013-1011-x","volume":"30","author":"S Absar","year":"2013","unstructured":"Absar S, Nahar K, Kwon YM, Ahsan F. Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy. Pharm Res. 2013;30(6):1663\u201376.","journal-title":"Pharm Res"},{"issue":"11","key":"1911_CR32","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1002\/jps.22160","volume":"99","author":"S Bai","year":"2010","unstructured":"Bai S, Ahsan F. Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism. J Pharm Sci. 2010;99(11):4554\u201364.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1911_CR33","first-page":"447","volume":"36","author":"OR Moss","year":"1979","unstructured":"Moss OR. Simulants of lung interstitial fluid. Health Phys. 1979;36(3):447\u20138.","journal-title":"Health Phys"},{"issue":"3","key":"1911_CR34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.14227\/DT180311P15","volume":"18","author":"RC Margareth","year":"2011","unstructured":"Margareth RC, Marques RL, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolut Technol. 2011;18(3):15\u201328.","journal-title":"Dissolut Technol"},{"issue":"1","key":"1911_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02630888","volume":"27","author":"JK Chen","year":"1991","unstructured":"Chen JK, Hoshi H, McKeehan WL. Stimulation of human arterial smooth muscle cell chondroitin sulfate proteoglycan synthesis by transforming growth factor-beta. In Vitro Cell Dev Biol. 1991;27(1):6\u201312.","journal-title":"In Vitro Cell Dev Biol"},{"issue":"1\u20132","key":"1911_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ijpharm.2011.04.017","volume":"413","author":"V Gupta","year":"2011","unstructured":"Gupta V, Ahsan F. Influence of PEI as a core modifying agent on PLGA microspheres of PGE(1), a pulmonary selective vasodilator. Int J Pharm. 2011;413(1\u20132):51\u201362.","journal-title":"Int J Pharm"},{"issue":"5","key":"1911_CR37","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.ejps.2013.06.004","volume":"49","author":"K Nahar","year":"2013","unstructured":"Nahar K, Gupta N, Gauvin R, Absar S, Patel B, Gupta V, et al. In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals. Eur J Pharm Sci. 2013;49(5):805\u201318.","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"1911_CR38","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1021\/mp300426u","volume":"10","author":"V Gupta","year":"2013","unstructured":"Gupta V, Gupta N, Shaik IH, Mehvar R, Nozik-Grayck E, McMurtry IF, et al. Inhaled PLGA particles of prostaglandin E(1) ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency. Mol Pharm. 2013;10(5):1655\u201367.","journal-title":"Mol Pharm"},{"issue":"2","key":"1911_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jconrel.2013.01.011","volume":"167","author":"V Gupta","year":"2013","unstructured":"Gupta V, Gupta N, Shaik IH, Mehvar R, McMurtry IF, Oka M, et al. Liposomal fasudil, a rho-kinase inhibitor, for prolonged pulmonary preferential vasodilation in pulmonary arterial hypertension. J Control Release. 2013;167(2):189\u201399.","journal-title":"J Control Release"},{"issue":"4","key":"1911_CR40","first-page":"1233","volume":"92","author":"JW Yoo","year":"2010","unstructured":"Yoo JW, Lee JS, Lee CH. Characterization of nitric oxide-releasing microparticles for the mucosal delivery. J Biomed Mater Res A. 2010;92(4):1233\u201343.","journal-title":"J Biomed Mater Res A"},{"issue":"6","key":"1911_CR41","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1517\/14712598.1.6.923","volume":"1","author":"N Maurer","year":"2001","unstructured":"Maurer N, Fenske DB, Cullis PR. Developments in liposomal drug delivery systems. Expert Opin Biol Ther. 2001;1(6):923\u201347.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"1911_CR42","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/08982100802465941","volume":"18","author":"MR Mozafari","year":"2008","unstructured":"Mozafari MR, Johnson C, Hatziantoniou S, Demetzos C. Nanoliposomes and their applications in food nanotechnology. J Liposome Res. 2008;18(4):309\u201327.","journal-title":"J Liposome Res"},{"issue":"1","key":"1911_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.yjmcc.2007.09.006","volume":"44","author":"SY Chan","year":"2008","unstructured":"Chan SY, Loscalzo J. Pathogenic mechanisms of pulmonary arterial hypertension. J Mol Cell Cardiol. 2008;44(1):14\u201330.","journal-title":"J Mol Cell Cardiol"},{"issue":"50","key":"1911_CR44","doi-asserted-by":"publisher","first-page":"21671","DOI":"10.1073\/pnas.1016233107","volume":"107","author":"TA Jarvinen","year":"2010","unstructured":"Jarvinen TA, Ruoslahti E. Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice. Proc Natl Acad Sci. 2010;107(50):21671\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"29","key":"1911_CR45","doi-asserted-by":"publisher","first-page":"20397","DOI":"10.1074\/jbc.M802850200","volume":"283","author":"X Yue","year":"2008","unstructured":"Yue X, Li X, Nguyen HT, Chin DR, Sullivan DE, Lasky JA. Transforming growth factor-beta1 induces heparan sulfate 6-O-endosulfatase 1 expression in vitro and in vivo. J Biol Chem. 2008;283(29):20397\u2013407.","journal-title":"J Biol Chem"},{"key":"1911_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1465-9921-7-2","volume":"7","author":"G Chen","year":"2006","unstructured":"Chen G, Khalil N. TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res. 2006;7:2.","journal-title":"Respir Res"},{"issue":"1","key":"1911_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1211\/jpp.59.1.0010","volume":"59","author":"S Chono","year":"2007","unstructured":"Chono S, Tanino T, Seki T, Morimoto K. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol. 2007;59(1):75\u201380.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"1911_CR48","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.3390\/ijms15034795","volume":"15","author":"E Frohlich","year":"2014","unstructured":"Frohlich E, Salar-Behzadi S. Toxicological assessment of inhaled nanoparticles: role of in vivo, ex vivo, in vitro, and in silico studies. Int J Mol Sci. 2014;15(3):4795\u2013822.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1911_CR49","doi-asserted-by":"publisher","first-page":"MR17","DOI":"10.1116\/1.2815690","volume":"2","author":"C Buzea","year":"2007","unstructured":"Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2(4):MR17\u201371.","journal-title":"Biointerphases"},{"issue":"6","key":"1911_CR50","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/jps.1023","volume":"90","author":"T Lian","year":"2001","unstructured":"Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90(6):667\u201380.","journal-title":"J Pharm Sci"},{"issue":"5","key":"1911_CR51","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1046\/j.1471-4159.1998.70051781.x","volume":"70","author":"WM Pardridge","year":"1998","unstructured":"Pardridge WM. CNS drug design based on principles of blood-brain barrier transport. J Neurochem. 1998;70(5):1781\u201392.","journal-title":"J Neurochem"},{"issue":"2","key":"1911_CR52","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2353\/ajpath.2007.061251","volume":"171","author":"TA Jarvinen","year":"2007","unstructured":"Jarvinen TA, Ruoslahti E. Molecular changes in the vasculature of injured tissues. Am J Pathol. 2007;171(2):702\u201311.","journal-title":"Am J Pathol"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-016-1911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-016-1911-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-016-1911-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-016-1911-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T08:15:39Z","timestamp":1589703339000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-016-1911-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":52,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1911"],"URL":"https:\/\/doi.org\/10.1007\/s11095-016-1911-7","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]},"assertion":[{"value":"13 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}